RecruitingPhase 4NCT04119180

Sedation Versus Protective Stabilization for Pediatric Dental Treatment

Sedation Versus Protective Stabilization for Dental Treatment of Children With Caries and Negative Behavior at the Dentist: a Non-randomized Clinical Trial


Sponsor

Universidade Federal de Goias

Enrollment

152 participants

Start Date

Jan 30, 2020

Study Type

INTERVENTIONAL

Conditions

Summary

There is a lack of evidence on the effectiveness of moderate sedation in pediatric dentistry, compared to protective stabilization, which remains routinely used in the Brazilian context despite moral questions. The objective of this prospective nonrandomized clinical trial is to evaluate the effectiveness of the use of moderate sedation, compared to the protective stabilization, in the dental care of children with fear / anxiety and / or dental behavior problem, and associated factors. The study will be carried out in outpatient clinics of the Dental Schools of the Federal University of Goiás (UFG) and University of São Paulo (USP), with the support of professors from King's College London through the partnership CEDACORE - Children Experiencing Dental Anxiety: Collaboration on Research and Education. Participants will be 152 children under 7 years of age with dental caries, who need specialized dental treatment due to a history of non-cooperation with dental care. The interventions to be compared are moderate sedation with oral administration of ketamine and midazolam (UFG) and protective stabilization (USP). The primary endpoint 'behavior / anxiety of the child during treatment will be assessed using the Ohio State University Behavioral Rating Scale. The secondary outcomes are: dental behavioral and anxiety evolution of the child, child' pain during procedure, impact on the quality of life related to oral health, parents and dentists' satisfaction and stress, adverse events for sedated participants, longevity of composite and glass ionomer cement restorations, chronotype and physiological stress of these children. A cost-efficacy analysis will be produced at the end of the study from the perspective of the Sistema Único de Saúde. Additionally, at the end of 36 months, the investigators expect to contribute to the identification of psychosocial aspects related to dental behavior problems in children in early childhood. It is important to highlight the perspective of technological innovation, with the creation of a digital platform that will allow the registration of data related to the dental care of children worldwide and favor analyzes in the methodology of data science.


Eligibility

Min Age: 1 YearMax Age: 7 Years

Plain Language Summary

Simplified for easier understanding

This study is comparing two approaches to managing anxiety and dental treatment in young children who need fillings: sedation (medication to calm the child) versus protective stabilization (physical support to keep the child safe during the procedure). The goal is to find the safest and most effective approach. **You may be eligible if...** - The child needs dental fillings or restorations - The child is generally healthy or has only mild, well-controlled medical conditions (such as controlled asthma) - The child has no neurological or cognitive impairment - The child does not take medications that affect thinking or behaviour - The child has a low risk of airway problems **You may NOT be eligible if...** - The child is already cooperative and calm during dental exams - The child has missed three scheduled appointments - The child uses systemic corticosteroids long-term Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGKetamine 50 MG/ML

Ketamine injectable solution in a concentration of 50.0 mg/mL via oral route; dose of 4.0 mg/kg maximum 100.0 mg

DRUGMidazolam Hcl 2Mg/Ml Syrup

Midazolam oral solution in a concentration of 2.0 mg/mL via oral route; dose of 0.5 mg/kg, maximum 5.0 mg when associated with ketamine;

PROCEDUREProtective stabilization

The legal guardian or accompanying person appointed by the legal guardian should sit in the dental chair with the child and contain leg and arm movements. A dental assistant keeps the child's head contained during care.


Locations(2)

Dental School - UFG

Goiânia, Goiás, Brazil

Dental School - FOUSP

São Paulo, São Paulo, Brazil

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04119180


Related Trials